Abstract
Humans are afflicted by the urinary stone disease since the dawn of time. Today this ailment is considered as the third most frequent urological pathological condition after infections and prostatic diseases, and statistics show a worldwide increase in its incidence and prevalence.
“One must be reasonable in one’s demands on life. For myself, all that I ask is: (1) accurate information; (2) coherent knowledge; (3) deep understanding; (4) infinite loving wisdom; (5) no more kidney stones, please.”
Edward Abbey (1927–1989)
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.
Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.
Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13:S45–50.
Pearle MS, Calhoun EA, Curhan GC, Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005;173(3):848–57.
Melnikow J, Xing G, Cox G, et al. Cost analysis of the STONE randomized trial: can health care costs be reduced one test at a time? Med Care. 2016;54(4):337–42.
Trinchieri A. Epidemiological trends in urolithiasis: impact on our health care systems. Urol Res. 2006;34:151–6.
Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management [quest]. Kidney Int. 2005;68:1808–14.
Treatment strategies for patients with renal colic: a review of the comparative clinical and cost-effectiveness [Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2014 Nov. CADTH Rapid Response Reports. http://www.ncbi.nlm.nih.gov/books/NBK263317/
Modersitzki F, Pizzi L, Grasso M, Goldfarb DS. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. Urolithiasis. 2014;42(1):53–60.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Al-Mamari, S.A. (2017). Introduction. In: Urolithiasis in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-62437-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-62437-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62436-5
Online ISBN: 978-3-319-62437-2
eBook Packages: MedicineMedicine (R0)